Jeffrey Sum Lung Wong

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 126 citations · Full text

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma

Hiroto Kikuchi, Aya Matsui, Satoru Morita et al. · JNCI Journal of the National Cancer Institute · 2022 · 67 citations · Full text

Recovery of malignant tumor cells from the right atrium during hepatic resection for hepatocellular carcinoma

Jarley Koo, Kin Fen Kevin Fung, K.F. Siu et al. · Cancer · 1983 · 51 citations · Full text

Right Atrium, Surgical Oncology, Pathology +17

Telomerase activity in small cell esophageal carcinoma

Vivian Chow, Simon Law, Alfred K. Lam et al. · Diseases of the Esophagus · 2001 · 25 citations · Full text

Esophageal Cancer, Malignant Disease, Oncogenic Agent +9

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

Jeffrey Sum Lung Wong, Gin Wai Kwok, Vikki Tang et al. · Journal of Clinical Oncology · 2021 · 23 citations

Immunology, Immunoediting, Advanced Hcc Patients +16